Literature DB >> 10678999

Lipopolysaccharide entry in the damaged cornea and specific uptake by polymorphonuclear neutrophils.

C L Schultz1, A G Buret, M E Olson, H Ceri, R R Read, D W Morck.   

Abstract

Bacterial lipopolysaccharide (LPS) is an important agent of induction of ocular pathology following corneal injury or wearing of contaminated contact lenses. The mechanism of LPS uptake through the corneal epithelium is unclear, and the role played by inflammatory cells in this phenomenon has not been previously assessed. Fluorescein isothiocyanate-labeled LPS from Escherichia coli was deposited onto the abraded corneas of New Zealand White rabbits. Epifluorescence microscopy of living excised corneas revealed diffuse LPS staining in the epithelial and stromal layers only in the vicinity of the abrasion. In addition, specific cellular uptake of LPS was suggested by fluorescence staining of cells along the abrasion site. In a second series of experiments, an anti-CD18 polyclonal antibody was used to block infiltration of polymorphonuclear neutrophils (PMN) into the cornea. In these experiments, a diffuse distribution of fluorescent LPS was still observed along the abrasion, but the specific cellular uptake was abolished. The findings indicate that LPS enters the cornea via diffuse penetration at sites of injury and that specific cellular uptake of LPS occurs within the cornea via PMN which have migrated into the damaged tissue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678999      PMCID: PMC97340          DOI: 10.1128/IAI.68.3.1731-1734.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Update in cornea and external disease: solving the mystery of "sands of the Sahara" syndrome (diffuse lamellar keratitis).

Authors:  S P Holland
Journal:  Can J Ophthalmol       Date:  1999-06       Impact factor: 1.882

2.  'Sterile' corneal infiltrates in contact lens wearers.

Authors:  A K Bates; R J Morris; F Stapleton; D C Minassian; J K Dart
Journal:  Eye (Lond)       Date:  1989       Impact factor: 3.775

3.  Marginal corneal infiltrates and ulcers.

Authors:  P THYGESON
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1947 Jan-Feb

Review 4.  Endotoxins and disease mechanisms.

Authors:  D C Morrison; J L Ryan
Journal:  Annu Rev Med       Date:  1987       Impact factor: 13.739

5.  Corneal ulcers associated with disposable hydrogel contact lenses.

Authors:  J P Dunn; B J Mondino; B A Weissman; P B Donzis; D O Kikkawa
Journal:  Am J Ophthalmol       Date:  1989-08-15       Impact factor: 5.258

6.  Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis.

Authors:  C A Lawin-Brüssel; M F Refojo; F L Leong; L Hanninen; K R Kenyon
Journal:  Cornea       Date:  1993-01       Impact factor: 2.651

7.  Corneal infiltrates with red eye related to duration of extended wear.

Authors:  T Crook
Journal:  J Am Optom Assoc       Date:  1985-09

8.  The interaction of Escherichia coli with normal human serum: factors affecting the capacity of serum to mediate lipopolysaccharide release.

Authors:  V L Tesh; D C Morrison
Journal:  Microb Pathog       Date:  1988-03       Impact factor: 3.738

9.  Lipopolysaccharide induced acute red eye and corneal ulcers.

Authors:  C L Schultz; D W Morck; S G McKay; M E Olson; A Buret
Journal:  Exp Eye Res       Date:  1997-01       Impact factor: 3.467

10.  Diffuse lamellar keratitis. A new syndrome in lamellar refractive surgery.

Authors:  R J Smith; R K Maloney
Journal:  Ophthalmology       Date:  1998-09       Impact factor: 12.079

View more
  9 in total

1.  Rocking media over ex vivo corneas improves this model and allows the study of the effect of proinflammatory cytokines on wound healing.

Authors:  Pallavi Deshpande; Ílida Ortega; Farshid Sefat; Virender S Sangwan; Nicola Green; Frederik Claeyssens; Sheila MacNeil
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-05       Impact factor: 4.799

2.  The role of toll-like receptor 4 in corneal epithelial wound healing.

Authors:  Medi Eslani; Asadolah Movahedan; Neda Afsharkhamseh; Herve Sroussi; Ali R Djalilian
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-02       Impact factor: 4.799

3.  Innate immune regulation of Serratia marcescens-induced corneal inflammation and infection.

Authors:  Rong Zhou; Rui Zhang; Yan Sun; Sean Platt; Loretta Szczotka-Flynn; Eric Pearlman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-25       Impact factor: 4.799

Review 4.  Toll-like receptors at the ocular surface.

Authors:  Eric Pearlman; Angela Johnson; Gautam Adhikary; Yan Sun; Holly R Chinnery; Todd Fox; Mark Kester; Paul G McMenamin
Journal:  Ocul Surf       Date:  2008-07       Impact factor: 5.033

5.  Ethyl pyruvate ameliorates endotoxin-induced corneal inflammation.

Authors:  Divya Gupta; Yiqin Du; Jordan Piluek; Adam M Jakub; Kristine Ann Buela; Akshar Abbott; Joel S Schuman; Nirmala SundarRaj
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-25       Impact factor: 4.799

6.  Inhibition of corneal inflammation by the TLR4 antagonist Eritoran tetrasodium (E5564).

Authors:  Yan Sun; Eric Pearlman
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

Review 7.  Contact lens-related corneal infection: Intrinsic resistance and its compromise.

Authors:  Suzanne M J Fleiszig; Abby R Kroken; Vincent Nieto; Melinda R Grosser; Stephanie J Wan; Matteo M E Metruccio; David J Evans
Journal:  Prog Retin Eye Res       Date:  2019-11-20       Impact factor: 21.198

Review 8.  Corneal Fibroblasts as Sentinel Cells and Local Immune Modulators in Infectious Keratitis.

Authors:  Ken Fukuda; Waka Ishida; Atsuki Fukushima; Teruo Nishida
Journal:  Int J Mol Sci       Date:  2017-08-23       Impact factor: 5.923

9.  Lack of MD-2 expression in human corneal epithelial cells is an underlying mechanism of lipopolysaccharide (LPS) unresponsiveness.

Authors:  Jing Zhang; Ashok Kumar; Michelle Wheater; Fu-Shin X Yu
Journal:  Immunol Cell Biol       Date:  2008-10-21       Impact factor: 5.126

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.